Scopus h-index:13
- Home
- Profiles
Video Visit Available
Accepting New Patients
Mount Sinai Doctors
Video Visit Available
Accepting New PatientsKeren Osman, MD
Cancer (Oncology), Hematology-Oncology
No Patient Experience Ratings
Ruttenberg Treatment Center
212-241-6021
- About Me
- Clinical Focus
- Video
- Education & Certifications
- Locations
- Insurance
- Publications
- Industry Relationships
About Me
Keren Osman, MD, is Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai (ISMMS). She is the Medical Director of the Cellular Therapy Service in the Bone Marrow and Stem Cell Transplantation Program at The Tisch Cancer Institute and The Mount Sinai Hospital. Before joining the faculty at Mount Sinai, Dr. Osman spent three years as a Clinical Scholar in a Tumor Immunology Laboratory at The Rockefeller University, where she studied dendritic cell vaccines for the treatment of advanced cancers. Dr. Osman specializes in AL amyloidosis and cellular therapy applications, including CAR T-cell therapy, for the treatment of advanced blood and solid tumor cancers.
Learn more about the Cellular Therapy Service here: https://www.mountsinai.org/care/cancer/treatments/cellular-therapy
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Keren Osman, MD, is Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai (ISMMS). She is the Medical Director of the Cellular Therapy Service in the Bone Marrow and Stem Cell Transplantation Program at The Tisch Cancer Institute and The Mount Sinai Hospital. Before joining the faculty at Mount Sinai, Dr. Osman spent three years as a Clinical Scholar in a Tumor Immunology Laboratory at The Rockefeller University, where she studied dendritic cell vaccines for the treatment of advanced cancers. Dr. Osman specializes in AL amyloidosis and cellular therapy applications, including CAR T-cell therapy, for the treatment of advanced blood and solid tumor cancers.
Learn more about the Cellular Therapy Service here: https://www.mountsinai.org/care/cancer/treatments/cellular-therapy
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Keren Osman, MD, is Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai (ISMMS). She is the Medical Director of the Cellular Therapy Service in the Bone Marrow and Stem Cell Transplantation Program at The Tisch Cancer Institute and The Mount Sinai Hospital. Before joining the faculty at Mount Sinai, Dr. Osman spent three years as a Clinical Scholar in a Tumor Immunology Laboratory at The Rockefeller University, where she studied dendritic cell vaccines for the treatment of advanced cancers. Dr. Osman specializes in AL amyloidosis and cellular therapy applications, including CAR T-cell therapy, for the treatment of advanced blood and solid tumor cancers.
Learn more about the Cellular Therapy Service here: https://www.mountsinai.org/care/cancer/treatments/cellular-therapy
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- AL Amyloidosis
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Allogeneic
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Hematology
Show More
- AL Amyloidosis
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Allogeneic
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Hematology
- Hodgkin's Disease
- Hodgkin's Lymphoma
- Leukemia
- Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myelofibrosis
- Transplantation
Video
Education
MD, Icahn School of Medicine at Mount Sinai
Residency, Internal Medicine
The Mount Sinai Hospital
Fellowship, Medical Oncology
Memorial Sloan-Kettering Cancer Center
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- Ruttenberg Treatment Center1470 Madison Avenue, 3rd Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- AgeWell New York
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Healthplus FKA Amerigroup Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Hotel Trades
- Magnacare-Health Care
- Medicare
- Metroplus
- Multiplan PHCS
- NY Medicaid
- Oxford - Freedom & Liberty
- Partners Health Plan
- Select Health Medicaid - VNSNY
- Senior Whole Health
- United Health Care - Community Care Medicaid
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Article:18
Review Article:2
Comment/Debate:1
Letter:5
Chapter:1
Recent Artifacts
- A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
- Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
- Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
- Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019
- COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter
- Bendamustine with dexamethasone in relapsed/ refractory systemic light-chain amyloidosis: Results of a phase II study
- Autologous stem cell transplantation for plasma cell disorders
- Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis
- Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation
- Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Osman during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Gilead Sciences, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.